Notable Labs Ltd
NASDAQ:NTBL

Watchlist Manager
Notable Labs Ltd Logo
Notable Labs Ltd
NASDAQ:NTBL
Watchlist
Price: 0.0255 USD Market Closed
Market Cap: 390k USD

Notable Labs Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Notable Labs Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Notable Labs Ltd
NASDAQ:NTBL
EPS (Diluted)
-$1
CAGR 3-Years
50%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
EPS (Diluted)
-$3
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
EPS (Diluted)
$0
CAGR 3-Years
-12%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Pluri Inc
NASDAQ:PLUR
EPS (Diluted)
-$2
CAGR 3-Years
34%
CAGR 5-Years
24%
CAGR 10-Years
21%
M
Matricelf Ltd
TASE:MTLF
EPS (Diluted)
₪0
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Notable Labs Ltd
Glance View

Market Cap
390k USD
Industry
Biotechnology

Notable Labs Ltd is a IL-based company operating in Biotechnology industry. Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The firm has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The firm's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.

NTBL Intrinsic Value
Not Available

See Also

What is Notable Labs Ltd's EPS (Diluted)?
EPS (Diluted)
-1.8 USD

Based on the financial report for Jun 30, 2024, Notable Labs Ltd's EPS (Diluted) amounts to -1.8 USD.

What is Notable Labs Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
37%

Over the last year, the EPS (Diluted) growth was 75%. The average annual EPS (Diluted) growth rates for Notable Labs Ltd have been 50% over the past three years , 37% over the past five years .

Back to Top